Final ID: 030
Manandhar Srista, Taylor Yhenneko, Bosworth Hayden, Pokharel Yashashwi, Chhetri Sunit, Sutton Danielle, Saha Animita, Kaur Suneet, Brown Josh, Moore Justin, Callahan Kate, Williamson Jeff
A First-In-Human Phase 1 Study of the Safety, Tolerability, and Pharmacodynamics of REGN7544, a Novel Natriuretic Peptide Receptor 1–Blocking Monoclonal AntibodyAhmed Mohsin, Morton Lori, Olenchock Benjamin, Herman Gary, Wynne Chris, Marin Ethan, Tuckwell Katie, Xu Meng, Cheng Xiping, Redington Emily, Koyani Bharatkumar, Mateo Katrina, Thakur Mazhar, Devalaraja-narashimha Kishor